---
figid: PMC10302309__pharmaceutics-15-01604-g002
figtitle: 'Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms
  to Clinical Application of New Therapeutic Strategies'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10302309
filename: pharmaceutics-15-01604-g002.jpg
figlink: /pmc/articles/PMC10302309/figure/F2
number: F2
caption: EGFR signaling pathway and EGFR-TKIs’ resistance mechanism
papertitle: 'The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular
  Mechanisms to Clinical Application of New Therapeutic Strategies'
reftext: Carmelo Laface, et al. Pharmaceutics. 2023 Jun;15(6).
year: '2023'
doi: 10.3390/pharmaceutics15061604
journal_title: Pharmaceutics
journal_nlm_ta: Pharmaceutics
publisher_name: MDPI
keywords: EGFR mutations | non-small cell lung cancer | tyrosine kinase inhibitors
  | resistance mechanisms
automl_pathway: 0.9618764
figid_alias: PMC10302309__F2
figtype: Figure
redirect_from: /figures/PMC10302309__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10302309__pharmaceutics-15-01604-g002.html
  '@type': Dataset
  description: EGFR signaling pathway and EGFR-TKIs’ resistance mechanism
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGFR
  - ALK
  - ROS1
  - ERBB3
  - ERBB2
  - RET
  - FGFR1
  - FGFR2
  - FGFR3
  - FGFR4
  - FGFRL1
  - NTRK1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - MMUT
  - KRAS
  - NRAS
  - ITK
  - SLC22A3
  - SERPINB3
  - SCLC1
  - PTEN
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - BRAF
  - AKT1
  - AKT2
  - AKT3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - MTOR
  - CCND1
  - CCND2
  - CCNE1
  - CDK4
  - CDK6
  - TP53
  - RB1
  - RBM45
  - MET
  - MEK
---
